Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Operating Margin (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Operating Margin for 11 consecutive years, with 606.49% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Operating Margin fell 42877.0% year-over-year to 606.49%, compared with a TTM value of 1205.01% through Dec 2025, down 86246.0%, and an annual FY2025 reading of 504.09%, down 40215.0% over the prior year.
  • Operating Margin was 606.49% for Q2 2025 at Wave Life Sciences, down from 542.82% in the prior quarter.
  • Across five years, Operating Margin topped out at 9.03% in Q3 2023 and bottomed at 13648.77% in Q3 2022.
  • Average Operating Margin over 5 years is 2405.62%, with a median of 542.82% recorded in 2025.
  • The sharpest move saw Operating Margin plummeted -1362789bps in 2022, then soared 1365780bps in 2023.
  • Year by year, Operating Margin stood at 2045.89% in 2021, then tumbled by -72bps to 3515.98% in 2022, then soared by 98bps to 64.3% in 2023, then crashed by -176bps to 177.72% in 2024, then crashed by -241bps to 606.49% in 2025.
  • Business Quant data shows Operating Margin for WVE at 606.49% in Q2 2025, 542.82% in Q1 2025, and 177.72% in Q2 2024.